Trials / Completed
CompletedNCT02261493
A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 787 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines \[crow's feet lines\]).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OnabotulinumtoxinA | OnabotulinumtoxinA injected into the protocol-specified areas. Subjects will receive at least 1 and up to 3 treatments. |
| DRUG | Normal Saline | Placebo (normal saline) injected into the protocol-specified areas on Day 1. |
Timeline
- Start date
- 2014-10-27
- Primary completion
- 2015-06-03
- Completion
- 2016-04-20
- First posted
- 2014-10-10
- Last updated
- 2017-07-25
- Results posted
- 2017-07-25
Locations
24 sites across 4 countries: United States, Belgium, Germany, United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02261493. Inclusion in this directory is not an endorsement.